Three-year Outcomes of Childhood Inflammatory Bowel Disease in New Zealand: A Population-based Cohort Study

Overview

Journal JGH Open

Specialty Gastroenterology

Date 2020 Aug 13

PMID 32782951

Authors

Natalie G Martin

Amin J Roberts

Helen M Evans

Jonathan Bishop

Andrew S Day

Affiliations

Soon will be listed here.

Abstract

Background And Aim: High rates of inflammatory bowel disease (IBD) have been documented in New Zealand (NZ) children. The objectives of this study were to describe the outcomes and disease course of childhood IBD in the first 3 years following diagnosis.

Methods: All children diagnosed with IBD in 2015 in NZ were included. Clinical data obtained during routine care for 3 years following diagnosis were analyzed. Growth parameters, disease activity scores, and blood parameters were compared at diagnosis and follow up.

Results: Three-year outcome data were available for 48 of 51 children. At follow up, median age was 15.1 years, and 34 had Crohn's disease (CD), 11 had ulcerative colitis (UC), and three had IBD-unclassified (IBDU). Although disease progression including development of perianal disease occurred in 13 (38%) of 34 children with CD, the majority ( = 30) had inflammatory disease at follow up. Disease extension occurred in 25% (2/8) of children initially diagnosed with UC. Of all IBD patients, the mean body mass index z-score increased from -0.40 to +0.10 ( = 0.01). Disease activity scores reduced from diagnosis to follow up in both CD (mean pediatric Crohn's disease activity index 35-6, < 0.001) and UC (mean pediatric ulcerative colitis activity index 44-6, < 0.001). Overall, 56% of children received steroids, 44% of children with CD received biologic therapy, and four children with CD or UC had intestinal surgery.

Conclusions: Most children with IBD were in remission with improved growth 3 years after diagnosis. Biologic therapies were commonly prescribed. This is the first NZ study assessing disease course in pediatric IBD. Ongoing follow up will continue to inform outcomes.

References

Lopez R, Evans H, Appleton L, Bishop J, Chin S, Mouat S . Prospective Incidence of Paediatric Inflammatory Bowel Disease in New Zealand in 2015: Results From the Paediatric Inflammatory Bowel Disease in New Zealand (PINZ) Study. J Pediatr Gastroenterol Nutr. 2017; 66(5):e122-e126. DOI: 10.1097/MPG.0000000000001806. View

Van Limbergen J, Russell R, Drummond H, Aldhous M, Round N, Nimmo E . Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008; 135(4):1114-22. DOI: 10.1053/j.gastro.2008.06.081. View

Griffiths A . Specificities of inflammatory bowel disease in childhood. Best Pract Res Clin Gastroenterol. 2004; 18(3):509-23. DOI: 10.1016/j.bpg.2004.01.002. View

Kang Y, Park S, Kim S, Kim S, Koh H . Therapeutic Efficacy of Exclusive Enteral Nutrition with Specific Polymeric Diet in Pediatric Crohn's Disease. Pediatr Gastroenterol Hepatol Nutr. 2019; 22(1):72-79. PMC: 6333584. DOI: 10.5223/pghn.2019.22.1.72. View

Levine A, Griffiths A, Markowitz J, Wilson D, Turner D, Russell R . Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011; 17(6):1314-21. DOI: 10.1002/ibd.21493. View

Lopez R, Appleton L, Gearry R, Day A . Rising Incidence of Paediatric Inflammatory Bowel Disease in Canterbury, New Zealand, 1996-2015. J Pediatr Gastroenterol Nutr. 2017; 66(2):e45-e50. DOI: 10.1097/MPG.0000000000001688. View

Kim H, Kim Y, Cho J, Oh S, Kim K . Therapeutic Efficacy of Oral Enteral Nutrition in Pediatric Crohn's Disease: A Single Center Non-Comparative Retrospective Study. Yonsei Med J. 2016; 57(5):1185-91. PMC: 4960385. DOI: 10.3349/ymj.2016.57.5.1185. View

Yap J, Wesley A, Mouat S, Chin S . Paediatric inflammatory bowel disease in New Zealand. N Z Med J. 2008; 121(1283):19-34. View

Kim H, Oh S, Kim D, Lee H, Park S, Yang S . Clinical Characteristics and Long-Term Outcomes of Paediatric Crohn's Disease: A Single-Centre Experience. J Crohns Colitis. 2016; 11(2):157-164. DOI: 10.1093/ecco-jcc/jjw146. View

10.

Martin-de-Carpi J, Rodriguez A, Ramos E, Jimenez S, Martinez-Gomez M, Medina E . Increasing incidence of pediatric inflammatory bowel disease in Spain (1996-2009): the SPIRIT Registry. Inflamm Bowel Dis. 2012; 19(1):73-80. DOI: 10.1002/ibd.22980. View

11.

Benchimol E, Fortinsky K, Gozdyra P, van den Heuvel M, Van Limbergen J, Griffiths A . Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2010; 17(1):423-39. DOI: 10.1002/ibd.21349. View

12.

Ishige T, Tomomasa T, Takebayashi T, Asakura K, Watanabe M, Suzuki T . Inflammatory bowel disease in children: epidemiological analysis of the nationwide IBD registry in Japan. J Gastroenterol. 2010; 45(9):911-7. DOI: 10.1007/s00535-010-0223-7. View

13.

Aloi M, Lionetti P, Barabino A, Guariso G, Costa S, Fontana M . Phenotype and disease course of early-onset pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2014; 20(4):597-605. DOI: 10.1097/01.MIB.0000442921.77945.09. View

14.

Gasparetto M, Guariso G, Visona Dalla Pozza L, Ross A, Heuschkel R, Zilbauer M . Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy. BMC Gastroenterol. 2016; 16:35. PMC: 4791934. DOI: 10.1186/s12876-016-0455-y. View

15.

Fumery M, Pariente B, Sarter H, Savoye G, Spyckerelle C, Djeddi D . Long-term outcome of pediatric-onset Crohn's disease: A population-based cohort study. Dig Liver Dis. 2019; 51(4):496-502. DOI: 10.1016/j.dld.2018.11.033. View

16.

Ruemmele F, Veres G, Kolho K, Griffiths A, Levine A, Escher J . Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis. 2014; 8(10):1179-207. DOI: 10.1016/j.crohns.2014.04.005. View

17.

Turner D, Hyams J, Markowitz J, Lerer T, Mack D, Evans J . Appraisal of the pediatric ulcerative colitis activity index (PUCAI). Inflamm Bowel Dis. 2009; 15(8):1218-23. DOI: 10.1002/ibd.20867. View

18.

Heyman M, Kirschner B, Gold B, Ferry G, Baldassano R, Cohen S . Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005; 146(1):35-40. DOI: 10.1016/j.jpeds.2004.08.043. View

19.

Vernier-Massouille G, Balde M, Salleron J, Turck D, Dupas J, Mouterde O . Natural history of pediatric Crohn's disease: a population-based cohort study. Gastroenterology. 2008; 135(4):1106-13. DOI: 10.1053/j.gastro.2008.06.079. View

20.

Nasiri S, Kuenzig M, Benchimol E . Long-term outcomes of pediatric inflammatory bowel disease. Semin Pediatr Surg. 2017; 26(6):398-404. DOI: 10.1053/j.sempedsurg.2017.10.010. View